Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s10384-014-0356-y.pdf
Reference34 articles.
1. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.
2. Chen YH, Lin HY, Hsu WM, Lee SM, Cheng CY. Retinoblastoma in Taiwan: incidence and survival characteristics from 1979 to 2003. Eye (London). 2010;24:318–22.
3. Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Exp Ophthalmol. 2010;38:638–43.
4. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: ‘chemosurgery’. The first Stallard lecture. Br J Ophthalmol. 2010;94:396–9.
5. Shields CL, Kaliki S, Rojanaporn D, Al-Dahmash S, Bianciotto CG, Shields JA. Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned? Curr Opin Ophthalmol. 2012;23:202–9.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Selective ophthalmic arterial injection using a balloon catheter for retinoblastoma: a seven-year clinical evaluation;Japanese Journal of Ophthalmology;2024-06-04
2. Revisión actualizada de la quimioterapia intraarterial para el retinoblastoma;Radiología;2024-05
3. Update on chemotherapy modalities for retinoblastoma: Progress and challenges;Asia-Pacific Journal of Ophthalmology;2024-03
4. Clinicodemographic profile, management, and treatment outcomes in advanced retinoblastoma at a tertiary care center in North India;Indian Journal of Ophthalmology;2023-12-15
5. A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients;Advances in Clinical and Experimental Medicine;2023-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3